Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Melanoma vaccines.

Miguel-Angel Perales¹, Jedd D Wolchok

¹Clinical Immunology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center and Joan and Sanford I. Weill Medical College of Cornell University, 1275 York Avenue, New York, NY 10021, USA. peralesm@mskcc.org

Cancer Investigation

|November 27, 2002

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Intravesical mesothelin-based CAR T cells targeting MUC16 effectively control bladder cancer in preclinical models.

The Journal of experimental medicine·2026

Same author

Immune checkpoint blockade augments lymphodepleting chemotherapy-induced antitumor immunity by expanding effector CD8+ T cell clones.

Cancer research·2026

Same author

Reprogramming of TLR-Ferroptosis Signaling and Immunometabolic Pathways Overcomes Myeloid Suppression to Improve Checkpoint Blockade in Prostate Cancer.

Cancer research·2026

Same author

Tumor-intrinsic expression of signal regulatory protein α contributes to the suppression of anti-tumor immune responses.

Cell reports·2026

Same author

Effective PD-1 checkpoint blockade in bladder cancer model requires tumor-draining lymph nodes and lymphocyte trafficking.

Urologic oncology·2026

Same author

Reply to: Blood-Brain Barrier Heterogeneity in NRG BN007: Implications for Immunotherapy Delivery.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

This review discusses strategies for developing melanoma vaccines to induce active immunity against tumor antigens. Understanding tumor immunity mechanisms and antigen identification are crucial for effective cancer immunotherapy.

Area of Science:

Immunology
Oncology
Vaccinology

Background:

Tumor antigen identification is key to advancing cancer immunotherapy.
Melanoma antigen vaccines are a major focus in cancer research.
Understanding tumor immunity and antigen escape mechanisms is vital.

Purpose of the Study:

To review strategies for inducing active immunity against melanoma.
To highlight the importance of antigen discovery in melanoma immunotherapy.

Main Methods:

Review of current research on melanoma antigens.
Analysis of mechanisms for inducing anti-tumor immunity.
Discussion of strategies for overcoming immune escape.

Main Results:

Related Experiment Videos

Multiple routes and mechanisms exist for inducing immunity against tumor antigens.
Active immunization strategies are being developed for melanoma treatment.

Conclusions:

Effective melanoma immunotherapy relies on understanding tumor antigens and immune responses.
Further research into active immunization strategies is essential for advancing melanoma treatment.